A n abdominal aortic aneurysm (AAA) is defined as a permanent dilation of the abdominal aorta by >50% or >3 cm and occurs in up to 8.00% of men over the age of 65 years and between 0.37% and 1.53% of women over the age of 60 years.
A n abdominal aortic aneurysm (AAA) is defined as a permanent dilation of the abdominal aorta by >50% or >3 cm and occurs in up to 8.00% of men over the age of 65 years and between 0.37% and 1.53% of women over the age of 60 years. 1, 2 Complications of AAAs, such as rupture or dissection, have an associated mortality of >80%. 3 Inflammation is of major importance in aneurysm formation and progression. 1, 4, 5 Patients with an AAA display increased serum concentrations of interleukin-1β, TNF (tumor necrosis factor) α, CCL2 (chemokine [C-C motif] ligand 2), interleukin-6, and interferon γ (IFNγ) while several inflammatory mediators affect AAA development in mice. [6] [7] [8] [9] Similarly, expression levels of matrix metalloproteinase (MMP) 9 are increased in human AAA tissue, and levels of tissue inhibitor of metalloproteinase-2 are decreased. 10 A TNF-related signaling pathway implicated in inflammation and matrix turnover is the CD40-CD40L dyad. 11 In atherosclerosis, inhibition of CD40-CD40L signaling decreases plaque size and results in a plaque phenotype that contains high amounts of fibrosis and low amounts of inflammation, reminiscent of a stable plaque. [12] [13] [14] [15] Here, we investigate the role of CD40L in AAA development in humans and mice. , separated into intima/medial and adventitial wall layers, and then stored in −80°C. RNA was isolated using Qiazol Lysis Reagent (Qiagen) and purified using the RNeasy minikit (Qiagen). The concentration of RNA was measured using Nanodrop ND 1000 (Thermo Fisher Scientific). Gene expression was analyzed with Affymetrix HTA 2.0 Genechip arrays (Thermo Fisher Scientific). Raw CEL intensity files were normalized through Guanine Cytosine Count Normalization, Signal Space Transformation, and Robust Multi-array Average by use of the Affymetrix Expression Console software (Thermo Fisher Scientific). The Bioconductor tool limma 16 was used in R 17 to determine differential gene expression, with the empirical Bayes moderation of standard errors for the microarray linear model. 
Materials and Methods

Microarray
Mice
Cd40l
−/− apolipoprotein E-deficient (Apoe
−/−
) and Apoe −/− mice on a C57BL/6 background were bred in our animal facility. More than 10 backcrosses with Apoe −/− mice were performed to obtain double knockout mice. Mice were fed a normal laboratory diet throughout the experiment. At 18 At the end of the experimental period, mice were euthanized after 4 hours of fasting. Blood was collected from the right ventricle for plasma cholesterol concentrations. The presence of macroscopic dissecting aneurysm and rupture was noted.
Mice were randomly divided into 2 groups. One group was used for histological and morphometric analysis (28 
Bone Marrow Transplantation
Apoe −/− mice (n=20) were lethally irradiated (10 Gy, 0. 
Histological Analyses
For morphometric analyses, the entire arterial tree was perfused with PBS containing 0.1 mg/mL sodium nitroprusside dihydrate (Sigma), followed by 1% paraformaldehyde via a catheter inserted into the left ventricle. The arterial tree was excised and fixed overnight in 1% paraformaldehyde and embedded in paraffin. Cross-sections (4 μm) of the suprarenal area of the abdominal aorta (with or without dissecting aneurysms) were obtained at 12 different levels at 200 μm intervals. Cross-sections from each level were stained with hematoxylin and eosin and Elastica von Gieson. Total vessel area on all 12 levels was measured on a Leica DM6000 Light microscope (Leica Microsystems) coupled to a computerized morphometry system (Leica Qwin 3.5.1).
Immunohistochemistry
To characterize accumulation of inflammatory cells in aneurismal tissue and the surrounding tissue, cross-sections were immunostained with anti-MAC-3 (BD Lifescience) for presence of macrophages, anti-CD45 (Becton & Dickenson) for leukocyte infiltration, and anti-CD3 (Dako) for T cell infiltration, anti-B220(1D3) for B cell infiltration, anti-CD4(RM4-5), or anti-CD8(5H10), kindly provided by Dr Duijvestijn. MAC-3, CD45, and CD3 immunostainings were quantified using a scoring system where no chromogen yielded a score of 0 and maximum color corresponded to a score of 5. Scoring was performed by 1 investigator blinded to the identity of the sections. The intraobserver variability was <10%.
RNA and Protein Analyses
Abdominal aortas of mice were excised for RNA or protein analyses and immediately snap frozen in liquid nitrogen and stored at −80°C until further use. The presence of a macroscopic visible aneurysm was documented.
RNA Isolation and Quantitative RealTime Polymerase Chain Reaction
Aortic tissues were homogenized, and RNA was isolated using the Qiagen RNeasy mini kit (Qiagen). For the preparation of cDNA, the iScriptcDNA Synthesis Kit (Bio-Rad) was used according to manufacturer's protocols. Quantitative polymerase chain reaction was performed using the SYBR Green method. A total of 10 ng of cDNA was used with the 2× quantitative polymerase chain reaction master mix (Bio-Rad). Expression of matrix metalloproteinases and their inhibitor genes pro-and anti-inflammatory genes and the regulatory T cell-specific gene Foxp3 were analyzed. Finally, CD40 and CD40L expression were analyzed. The reference genes cyclophilin A and β-actin were used to normalize RNA abundance.
Gelatin Zymography
MMP-2 and MMP-9 activities were determined in aortic/aneurysm tissues of Apoe −/− and Cd40l −/− Apoe −/− mice. Tissue samples were extracted in 150 µL sodium dodecyl sulfate lysis (10% glycerol, 20% sodium dodecyl sulfate, 10% 1.5 mol/L Tris pH 6.8) buffer by cutting the tissue into small pieces after which total protein concentration was adjusted to 75 μg. Murine vascular smooth muscle cells incubated with TNF-α+platelet-derived growth factor was used as a control. MMP-2 and MMP-9 activities in extracts were detected as described previously. 19 Briefly, 4 µL of tissue extract was diluted (1:5) with distilled water. Samples were electrophoresed in the presence of nonreducing buffer at 4°C in 7.5% sodium dodecyl sulfate polyacrylamide gels containing 2 mg/mL gelatin. After the removal of sodium dodecyl sulfate, gelatinase activity was revealed by overnight incubation at 37°C and subsequent staining with 0.1% Coomassie brilliant 
Lipid Analyses
Plasma cholesterol concentrations were measured using an enzymatic assay (Roche).
Statistical Analyses
Data are expressed as mean±SEM. The Mann-Whitney nonparametric test was used to compare the Cd40l −/− Apoe −/− and Apoe −/− groups. When analyzing incidence of aneurysm formation and incidence of death before end of the experiment, the Fisher exact test was used. Kaplan-Meier survival curves were analyzed using log-rank (MantelCox) test. Flow cytometry data were analyzed using Student t test. Data with probability values <0.05 were considered statistically significant.
Results
Increased Expression of CD40L and CD40 in Human AAA
Microarray data from the Stockholm AAA Biobank were used to study the expression levels of CD40L and CD40 mRNA in human AAA disease. Tissue samples of thrombus-free (n=34) and thrombus-covered (n=76) AAA wall segments, collected from open aortic repair conducted between the years 2009 and 2016, as well as tissue samples of nonaneurysmal abdominal aorta (n=13), obtained from solid organ transplant surgeries performed in 2014, were immersed immediately in RNA stabilization solution and then separated into intima/medial and adventitial layers. Microarray-based gene expression analyses of these samples revealed overexpression of both CD40 and CD40L in the thrombus-free and thrombus-covered AAA aortic media compared with control aortic media (Figure 1 ). In mice, CD40L expression was also increased in the abdominal aorta when comparing Apoe −/− mice who did not receive AngII infusion to mice receiving AngII for 7 days (relative expression±SEM 0 versus 7 versus 28 days Ang II=0 days: 1.00±0.37 versus 7 days: 2.12±0.15 versus 28 days: 1.04±0.60). 
CD40L Deficiency Protects Against AngII-Induced Dissecting Aneurysm Formation in
Cd40l
−/− Apoe −/− chimeras were protected from death by aneurysm rupture indicating a strong contribution of hematopoietic CD40L in the pathogenesis of aneurysm formation ( Figure IIIA and IIIB in the online-only Data Supplement).
CD40L Deficiency Reduces Proteolytic Activity
Paralleling the decrease in inflammation, absence of CD40L significantly reduced indicators of proteolytic activity. After 28 days of AngII infusion, MMP-13 mRNA levels were decreased, whereas tissue inhibitor of metalloproteinase-3 mRNA abundance increased in the abdominal aorta of Cd40l 
CD40L Deficiency Is Protective in Early Aneurysm Development
To identify processes preceding mature aneurysm formation, mice were analyzed after only 1 week of AngII infusion. Initial signs of aneurysm formation (visible dilatation, vascular hematomas) were present in a large portion of Apoe −/− mice after 7 days of infusions, with a lower incidence in the The fraction of CD4 + FoxP3 + regulatory T cells was also decreased ( Figure 5F ). However, this can be explained by a negative effect of inhibiting CD40-CD40L on regulatory T cells via interleukin-2-mediated decreased regulatory T cell expansion and survival after dendritic cell encounter as described previously. 
Discussion
Here, we show that CD40L deficiency strongly reduces the incidence of dissecting aneurysms by limiting inflammation and extracellular matrix degradation in the arterial wall. However, once a dissecting aneurysm develops, CD40L deficiency cannot prevent the progression as shown by similar sizes of developed aneurysms.
We found that CD40L deficiency especially dampened Th1 (T helper 1)-related cytokines in aneurysms and that production of these cytokines via CD40-CD40L signaling is imperative in dissecting aneurysm formation. This observation is in agreement with an AAA-eliciting role of the hallmark Th1 cytokines IFNγ and TNFα as reported before. 21, 22 However, there is still debate and contradiction whether AAA is promoted by Th1-, Th2-, or Th17-dominated cytokine responses, and multiple reports have conflicting outcomes. 4, 6, 23 Xiong et al 22 showed a pivotal role for TNFα in calcium chloride-induced AAAs, whereas Shimizu et al 24 showed that allograft AAAs were increased in IFNγ-deficient mice and harbored a Th2-skewed cytokine environment. Zhou et al 25 found a pathogenic role for IFNγ-producing CD8 + T cells and found that IFNγ antagonism prevents disease in wild-type mice in an elastase-infusion model. However, King et al 26 observed greatly increased aneurysm severity in AngIIinduced dissecting aneurysms in IFNγ −/− mice. Yet, in mice lacking CD40L, we observed a decrease in TNFα at day 7, as well as IFNγ, and interleukin-12 28 days postaneurysm initiation, respectively. These findings are in accordance with previous studies underlining the importance of Th1 cytokines and reflect the complex role of cytokines in aneurysm pathophysiology. Indeed, different cytokines, chemokines, and proteases seem affected by CD40L at different time points in the disease process. The significant decrease in the inflammatory subsets of T cells and monocytes in Cd40l −/− Apoe −/− mice, combined with the aforementioned decrease in proinflammatory cytokines and chemokines, points toward a generalized reduction in the inflammatory status of these mice. This is in accordance with the strong proinflammatory effects of CD40-CD40L signaling in other disease models. 11, 17 Another cytokine/growth factor imperative for AAA development is TGFβ (transforming growth factor beta). 27 However, the specific role is controversial. Notably, TGFβ abundance is increased in AAA vascular tissue, both in syndromic diseases, such as Marfan, as well as nonsyndromic disease. 28 TGFβ activity was recently ascribed a protective function against AAA formation, in particular via a key component of the canonical TGFβ signaling pathway, SMAD3. 7, 29 We observed a modest decrease in TGFβ levels after 7 days but no change after 28 days in CD40L deficiency, suggesting that CD40L mostly drives inflammation during disease initiation. Discrepancies in study results may derive from different models used to induce AAA with diverging pathophysiological mechanisms. 30 Modulation of MMP activity and other proteolytic mediators is an important mechanism in reducing the incidence of AAA. 31 Mice deficient in MMP-2, MMP-3, and -9 displayed fewer AAAs. 32, 33 CD40L is a potent inducer of MMP activation. 11 Accordingly, CD40L deficiency resulted in decreased MMP-2 and -9 activity and MMP-13 mRNA abundance in AAA tissue. Interestingly, we found that the effects on inflammation preceded effects on proteolysis as shown in the difference between findings after 7 and 28 days. This indicates an early effect of CD40L on inflammation in the formation of dissecting aneurysms while at later time points, proteolysis and extracellular matrix degradation seem affected by CD40L in AngII-induced dissecting aneurysms.
Although this study is the first to examine the effects of CD40-CD40L signaling on aneurysm formation in a gene-deficient model, previous studies have investigated CD40-CD40L as a potential biomarker or therapeutic target. The antiplatelet drug trapidil, which inhibits CD40-CD40L, among other functions, when used on tissue from human AAA patients, inhibits MMP-2 but not MMP-9. 34 Interestingly, an anti-CD40L monoclonal antibody also only selectively blocked MMP-2. 34 In the present study, we found a significant decrease of only MMP-13 mRNA levels although we noticed decreased activity of MMP-2 and (pro)MMP-9 by gelatin zymography.
Thus far, no correlation of (s)CD40L levels with AAA incidence have been reported. 35, 36 However, concentrations of sCD40L, mainly secreted by platelets, are not necessarily related to local CD40-CD40L activity nor rule out a function of CD40-CD40L signaling in disease pathology, as also seen by conflicting data on sCD40L as a biomarker for cardiovascular disease, despite a proven role of CD40-CD40L in atherosclerosis. 17 Furthermore, when measured inside the luminal thrombus layer from patients with AAA in a separate study, sCD40L levels were increased compared with other layers. 37 In addition, plasma levels of sCD40L were increased in patients compared with controls underlining a potential role for CD40L in human disease and reflecting the results of our study. 37 We now show that indeed, transcript levels of CD40 and CD40L are increased in the arterial media of human thrombus-free or thrombus-covered AAA compared with nonaneurysmal control vessels.
Lack of CD40L mitigated dissecting aneurysmal disease both in a full gene-deficient as well as in a bone marrow transplant model, suggesting that CD40L on hematopoietic cells is a major contributor to the pathogenesis of dissecting aneurysm formation. However, a role of CD40L on nonhematopoietic cells cannot be ruled out. Moreover, as of now, it is unclear on which cell types CD40L exerts its effects or which signaling pathways are responsible for these effects of CD40L. Further studies using cell-specific gene-deficient models and inhibition of specific parts of the CD40-CD40L signaling cascade will further elucidate the function of this potent costimulatory molecule pair in vascular disease, including AAA, and potentially direct new therapeutic strategies.
To date, therapeutic options preventing growth or rupture of AAA are limited, and surgical interventions remain challenging, especially in the elderly. Therefore, novel pharmacological strategies are an unmet medical need in patients. Our data reveal that blocking CD40L protects the arterial wall from dissecting aneurysm formation by reducing the proteolytic profile, preceded by reduced inflammation. This protection is associated with lower risk of rupture. Thus, therapies inhibiting CD40L or downstream targets in the CD40-CD40L pathway may pose an attractive option for the stabilization of AAAs. 
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